Episode 8: Patient Complaints

Episode 8: Patient Complaints

On this episode of the EM Ottawa Podcast, Dr. Rajiv Thavanathan talks to  Dr. Nicholas Schouela to discuss the patient complaints process, approaches and mitigation strategies. 

 

Why do they matter?

They’re common. They’re associated with shame and distress. We’re generally high achieving people who take perceived failures poorly. Importantly, many are based on legitimate patient safety issues. By addressing this, we can work towards improving patient safety.

 

What has changed recently in the patient safety landscape?

In Canada, between 2016-2020, there was a 20% increase in college complaints across all specialties. The ED sees the 3rd highest rate of college complaints across all specialties; for reference, the highest being obstetrics & gynecology, and the second being general surgery.

 

How did Covid-19 influence patient complaints?

Despite decreased patient volumes during the initial phases of the pandemic, complaints continued to rise increasing locally in Ottawa by 22%.

 

What guidelines or legislation exist for hospitals in managing the complaint process?

All provinces have essentially mandated that patient complaints are taken seriously and in a structured way.

Ontario has the Excellent Care for All Act. This is a piece of legislation that was developed to increase the focus and accountability for delivering high-quality care through the initiation of multiple hospital and government level committees.

 

What is the CMPA, and what is its role in patient complaints?  

The CMPA is a not-for-profit defense association, they provide medical legal advice and assistance, patient compensation, resource for risk management, and they write medical-legal opinions for public policy. For patient complaints, they are there to advise, and if needed provide legal counsel.

What are the steps involved after receiving a patient complaint at the college level?

One of the first steps should involve contacting the CMPA. You should not attempt to access or edit the patient’s chart. Following this, you respond to the complaint with the CMPA’s help. Following your response, the CPSO begins the investigative process; this can take between 3 to 10 months. It then takes 2 to 3 months to formulate a decision; essentially a year-long process.

 

What are common pitfalls made in responding to patient complaints?

  • Opening the patient’s chart without permission. You need permission from your local hospital to do so as the information does not belong to you.
  • Trying to edit the note or the encounter. If you alter the patient encounter, your credibility is instantly lost.
  • Responding too emotionally or defensively. You want to remain factual and even-toned.

 

What are the outcomes of complaint decisions?

Split into favorable or unfavorable outcomes. Favorable essentially meaning you were in the right. Unfavorable outcomes include cases that were dismissed with concern, suspensions, restrictions placed on a license, revoking of a license, or voluntary resignation or resignment.

 

Why do patients complain?

Multiple reasons, although most commonly due to a perceived injustice. A 2018 ED study by the CMPA showed that approximately half of all patient complaints involved scenarios that resulted in patient harm. Of these harm-scenarios, 90% of medical experts were critical of the initial care provided. 

Complaints can be divided into three different categories: Clinical care, situational awareness, or a communication breakdown.

 

What deficiencies were identified by the CMPA as leading to complaints?

The vast majority pertain to inadequate patient assessments. A good proportion also include failure to refer to appropriate consulting services, and inadequate or incomplete investigations.

 

What are situational awareness complaints?

On average, 1 out of every 5 complaints are based on situational awareness. These include monitoring issues, such as a patient that should have been on a monitor but was placed in an unmonitored area and harm resulted. This further includes tests that were sent off and not followed up on, patients discharged prior to abnormal lab values resulting, or the physician performing an incomplete review of the medical chart leading to suboptimal care.

 

What is communication breakdown from the CMPA standpoint?

On average, 1 out of every 4 complaints relate to communication breakdown. These can be divided into four broad categories: physician to patient communication, inter-physician, physician to other allied health providers, and documentation.

Is communication modifiable in reducing patient complaints?

Absolutely. Improving communication can also improve your decision making and situational awareness.

 

What aspects of handover may reduce patient complaints?

Handover is a high-risk time of physician-to-physician communication breakdown. Poor handover increases the risk of patient harm, time in the department, and investigations.

Dr. Ed Kwok, in a 2020 study identified that ¼ of patients were inadequately handed over, with up to ½ of patients consulted inadequately handed over.

Ultimately, the risks associated with missing key information in handover can be minimized by using a standardized framework, such as ED VITALS.

 

Beyond a standardized handover framework, how can we further improve communication?

Disclosing non-clinically relevant abnormal results. Particularly if patients have access to reviewing their own labs or electronic charts, as this can be distressing to patients. Addressing all incidental findings on imaging, even if it simply means following up with their primary care provider in 6-months to repeat the test.

 

Tips for disclosing errors

Firstly, certain situations mandate the disclosure of error. This includes any incident that leads directly to patient-harm, or that reached the patient and had the potential for harm, even if it didn’t cause any harm. Generally, it’s a good idea to disclose any incident that reaches the patient even if it didn’t have the potential for harm.

 

Any pearls or pitfalls for apologizing to patients?

An apology in the form of a statement of regret is both a good idea and can help with emotional healing. This is protected across Canada in different provincial acts as not being considered an admission of fault. For reference, in Ontario, this act is called the Apology Act. 

 

What are the critical elements of discharge instructions that can minimize patient complaints?

This is the final impression you give to a patient and relays critical information. You should include advise specific to their condition, a follow-up plan, the signs and symptoms in which you would want them to seek care again and make it clear that they are always welcome to return. This should be done verbally at a minimum; however, written handouts can be a nice compliment to this.

 

Where do we go wrong with obtaining and documenting consent in the ED?

Two different categories. The first is forgetting to obtain consent entirely, which can lead to allegations of battery. The second is a consent process that fails to adequately inform them. Recall that consent includes multiple components: it needs to be voluntary, the patient needs to have capacity, they need to be properly informed about the risks, benefits, alternatives, and consequences of declining the procedure.

 

In the age of electronic charting, what are the medicolegal risks of using pre-filled templates or dot-phrases?

While largely beneficial, they can lead you to documenting things you didn’t do, which can of course harm you medicolegally. There hasn’t been a specific CMPA judgement on this that the authors are aware of.

 

Any advice to be more empathetic or caring for patients in the emergency department?

Remember that patients present to the ED because they have a worry or concern. Even if they don’t have underlying emergent pathology, they don’t feel well. Using empathy to address these concerns remains paramount. Additionally, use a patient-centered approach with culturally appropriate care. 

 

What practical advice do you have for physicians dealing with patient complaints?

Recognize that these aren’t easy. We will all receive at least one during our career no matter how careful we are. We know that complaints can cause significant emotional distress, anxiety, depression, substance abuse, social withdrawal, work disruptions, insomnia, loss of trust in patients, and feelings of helplessness. Self-care is important: exercise, mindfulness, and seeking out supportive people in your network or professional support. There are provincial medical associations physician help programs. If you work out of a university, there are also university affiliated faculty wellness programs. The CMPA itself also has several resources and guides.

 

Any practical strategies that can be exercised independently?

Cognitive strategies, such as the best-friend strategy, which involves treating yourself how you would treat your best friend if they came to you in the same scenario. Reflect on maintaining a growth mindsight and consider reviewing your knowledge base if there were any identified areas of deficit. Most importantly, practicing self-care as emphasized above.

 

 

Episode 7: Anaphylaxis Part I, Refine your Approach

Episode 7: Anaphylaxis Part I, Refine your Approach

Today, we’ve got not one, but two guest experts to help Dr. Rajiv Thavanathan tackle all things Anaphylaxis! Dr. Graham Wilson is an FRCPC EM resident at The Ottawa Hospital (TOH), who tackled this topic in-detail in his Grand Rounds presentation last year. Joining him is Dr. Derek Lanoue, an incoming McGill Allergy and Immunology Fellow. Let’s dive right in to Part 1 of 2 on this nutty topic!

What is the Diagnostic Criteria of Anaphylaxis?

It’s very difficult to summarize “anaphylaxis” in one definition. To tackle this problem, in 2005, The National Institute of Allergy and Infectious Diseases, and Food Allergy and Anaphylaxis Network came out with the criteria most ED docs probably teach on shift today.

2005 NIAID and FAAN Anaphylaxis Criteria

  • Anaphylaxis is highly likely if:
    • Unknown exposure with acute onset of illness
      • AND Skin OR mucosal changes
      • AND Respiratory compromise OR reduced blood pressure
    • Likely antigen:
      • Two or more organ system involvement: Skin, mucosa, respiratory system, cardiovascular changes, or persistent GI symptoms
    • Known allergen:
      • Reduction in blood pressure

This definition was prospectively validated with a sensitivity 95%, though we aren’t applying it as effectively as it should. A study in the USA by Russell et al. in 2013, and more recently out of the Childrens Hospital of Eastern Ontario in 2020 show that:

  • We are underdiagnosing anaphylaxis upwards of 50% of the time
  • Why? Definitions are too restrictive.
  • “What do persistent GI symptoms even mean?” “Is one episode of emesis enough?”

 

Things changed for the better in 2020, when the World Allergy Organization tried to simplify things for practitioners. 

2020 World Allergy Organization Anaphylaxis Criteria

  • Anaphylaxis is highly likely if:
    • Unknown exposure with an acute onset of illness
      • Skin findings, and one other organ system
    • Likely or known antigen
      • Respiratory AND/OR cardiovascular compromise

 

How can we improve allergy/immunology referrals?

The purpose of our anaphylaxis criteria is to maximize sensitivity to not miss this life-threatening diagnosis, and to administer the antidote, epinephrine, as soon as possible. This poses the question though – what might this approach be sacrificing, from the perspective of the consultant who will see this patient in follow up?

Dr. Lanoue brings up a great point – it’s all in the objective evidence. Did you hear wheezing when you examined them? Do they have hives you can photograph (with consent)? Have they vomited? How many times? Did they have an episode of diarrhea in the ED?

“Okay, but what about tryptase?”

Triptase is an intermediate in anaphylaxis, which causes activation of the compliment system, and mast cell degranulation. This test takes ages to come back, so often it won’t get drawn as part of the work-up for anaphylaxis – some centres won’t have it?

Dr. Lanoue recommends the following from the allergists’ perspective:

  • For the vast majority, get the level.
  • It doesn’t help in the acute setting; it won’t help you decide whether to give epinephrine or not.
  • It can be very useful, however, for the consultant allergist.
  • The level peaks within an hour, and is back to normal within 4-6h. Any patient who presents within this time period from onset may have benefit.

Tryptase levels are useful in the patient where there is an unclear trigger. We know there will be many patients who are tryptase negative, despite being in anaphylaxis. The reverse is also true. In the setting of an unknown trigger, especially when there is diagnostic uncertainty, this may provide another objective piece of evidence for your consultants. Anaphylaxis is not the only diagnosis that is indicated by an elevated tryptase (e.g. mast cell degranulation syndrome).

What is the dosing of epinephrine for anaphylaxis?

  • Epinephrine: 0.01mg/kg, up to a max of 0.5mg.
  • Anyone below 25kg: 0.15mg Epinephrine auto-injector (e.g. Epipen Jr).
  • Anyone above 25kg: 0.3mg Epinephrine auto-injector (e.g. Epipen).
  • We can provide weight-based dosing in the hospital setting, and encourage listeners to do the same to get the most benefit from epinephrine as possible.
  • No established RCT on dosing. Even the 0.01 mg/kg is opinion-based, and based on data on normal adults, not those having anaphylaxis, using measured levels of epinephrine in the blood level.

 

What is the ideal site of administration for anaphylaxis?

Dr. Estelle Simons is a (Canadian!) prolific researcher in the field of Allergy and anaphylaxis and has served as president of the American Academy of Allergy, Asthma and Immunology (AAAAI). She performed a study measuring peak epinephrine concentrations in healthy, adult volunteers in the deltoid muscle vs the lateral thigh, showing a higher level in the lateral thigh. This is likely due to a higher concentration of vasculature. More of her work showed a difference in the rates of absorption in intramuscular vs subcutaneous administration of epinephrine. Other researchers have demonstrated that the thinner subcutaneous tissue over the lateral thigh allows for more consistent penetration to the muscle.

In summary, use the lateral thigh and use the intramuscular route.

Another huge take away point by both guest speakers is that IV bolus delivery of epinephrine for the treatment of anaphylaxis is associated with increased adverse outcomes compared to both IM and SC.

Use of steroids and antihistamines

These are a very controversial topics, with lots of dogma surrounding the medications we use. In theory, steroids work in two ways. First, it decreases the symptom burden in the acute phase of anaphylaxis. Second, it helps to prevent the concerning, though ever-elusive unicorn that is the biphasic reaction.

In the acute phase, the evidence from steroids came from children with asthma and croup, looking at preventing hospital admissions, and relapse rates. Maximum steroid serum concentrations occur within 1-2 hours, which means that it’s highly unlikely to prevent death from anaphylaxis. We know that death from anaphylaxis occurs within 30 minutes of trigger exposure, which is well outside of the effective window for the steroid.

What we do know is that epinephrine is the first-line intervention for anaphylaxis, with the greatest mortality benefit. Despite, in a cohort study of close to 2000 children diagnosed with anaphylaxis, less than 25% received epinephrine, with almost 50% received steroids.

So what about the biphasic reaction? The biphasic reaction is recurrent anaphylaxis, after complete resolution of symptoms, without re-exposure, within 72 hours of the initial anaphylactic event.

A few facts about the biphasic reaction:

  • Rates range from 4-5% of anaphylaxis cases using the above definition.
  • Most present in a clinically similar manner to the first episode.
  • Only 20% of these patients required additional therapy on top of what they originally received.
  • Steroids in the ED first gained favor in 2007 when a single-centre prospective study showed decreased biphasic reactions with use of steroids.
  • Since that time, several systematic reviews argue against preventative association of biphasic reactions, and one study went so-far as to recommend against the routine use of steroids for anaphylaxis.
  • Further, there have been no reported cases of mortality due to biphasic anaphylaxis as per the 2020 AAAAI Practice Parameters
  • Clinical Features of biphasic anaphylaxis (low-quality evidence):
    • Those who required multiple epinephrine doses
    • Respiratory failure, end-organ damage, cardiovascular shock or arrest.

 

In summary, don’t extrapolate too much, but the routine use of steroids is probably not ideal. There are, however, select patients that will still benefit:

  • Refractory anaphylaxis
  • Cardiovascular shock
  • Concurrent asthma with anaphylaxis (clear benefit shown with steroids)

 

“If I’m going to use a steroid, which one should I use?”

If you choose to use a steroid, a careful agent selection that is ideal for your patient can have a much greater benefit than simply throwing IV methylprednisolone at them.

  • Methylprednisolone is associated with the highest rates of steroid-induced anaphylaxis, urticaria, and angioedema of all steroids
  • For this reason, consider using dexamethasone vs hydrocortisone, letting the patients presentation guide our choice
    • When to consider dexamethasone: Dominant upper/lower respiratory involvement are responsive to this medications anti-inflammatory effects, as well as its longer duration of action.
    • When to consider hydrocortisone: If the patient continues to be hypotensive, mineralocorticoid effects from hydrocortisone may play a higher benefit in this shock or shock-like state.

If there’s one take home point from biphasic reactions and steroid use, it’s that the number one medication to prevent relapse and bounce-back from anaphylaxis is epinephrine.

For part 2 episode and show notes, click here !

Episode 7: Anaphylaxis Part I, Refine your Approach

Episode 7: Anaphylaxis Part 2, Ready for Discharge

In part 2 of our 2-part series on Anaphylaxis, our host Dr. Rajiv Thavanathan interviews Dr. Graham Wilson, PGY4 Emergency Medicine at the University of Ottawa and Dr. Derek Lanoue, PGY3 Internal Medicine, University of Ottawa who will soon be an Allergy and Immunology Fellow starting July 1, 2022.

If you haven’t already, you should check-out Part 1 of the series, where the new definition for anaphylaxis and treatment guidelines, including the use of steroids were discussed.

In this part 2, let’s delve deeper into the subject, by discussing monitoring times, discharge instructions and follow-up.

Anaphylaxis Monitoring Times

Although easy to treat with the use of epinephrine, anaphylaxis management is labour intensive in the emergency department with regards to cost effectiveness and human resources, due to the often long “observation” time in the ED. These observation times have a single purpose – monitor for a refractory/biphasic reaction.

Throughout the literature on the topic, there is a wide variation on what is perceived to be an acceptable “mandatory” observation time [range extends between 2-24hrs]. Given the lack of consensus on a set timeframe, some literature has focused on trying to identify this value. A recent study by Ellis has successfully identified that the NPV for the observation of biphasic reaction only increases by 1% for every hour since time of epinephrine injection. This is one of the landmark trials questioning the need for extended observation, primarily for low-risk asymptomatic individuals 1-2hrs post epinephrine injection.

With these promising results, it wouldn’t be inconceivable to think that in the not-so-distant future, risk stratification could be used, and shorter observation periods considered for low-risk individuals. This would certainly help with the human/costly resources needed for extended observation periods.

This conclusion somewhat aligns itself with the 2020 Anaphylaxis guidelines which suggest firmly that high-risk patients require observation for a minimum of 6 hours. These high-risk patients are defined by:

  • Risk Factors: Lack of EMS services, Poor self-management skills, cardiovascular risk factors, and lack of access to epinephrine
  • Requirement for several doses of epinephrine
  • Severe anaphylaxis

 

Anaphylaxis Mimics: What the ED MD needs to know

Even anaphylaxis has its mimics. These diagnoses are hard to elicit in the moment when a patient presents to the ED with stridor, wheezing and respiratory distress. As such, it’s completely understandable that most ED physicians will provide these patients with at least 1 dose of epinephrine up front. However, if the patient is not responding to epinephrine, there are a few diagnoses that we should perhaps consider.

  • Chronic urticaria [including dermatographism]: This condition, whose pathophysiology is best explained as a hypersensitivity reaction, results in exaggerated weal and flare response to a stimulus – for example physical pressure (being stroked or scrathched) in the case of dermatographism. The condition may respond to the use of antihistamines. It often is an anaphylaxis mimicker when the urticaria is perioral and/or associated with a panic attack, resulting in the physical presentation of tachypnea and dyspnea.
  • Vocal cord dysfunction: This entity is often seen in individuals with allergies to perfumes or other aerosolizing products. In anaphylaxis cross-linking of IgE results in mast cell degranulation. Aromatic rings found in perfumes are incapable of cross-linking IgE or entering the blood stream, and as a result only stimulate a localized hypersensitivity reaction.

In addition to the above mimics, there are several instances when seeing a patient, where the dx of anaphylaxis seems clear from a symptom’s perspective, but the identification of triggers is difficult. It’s important to remember that idiopathic anaphylaxis is a medical entity of its own and is defined by sx of anaphylaxis with no clear trigger.

Furthermore, with the arrival of Lonestar ticks in Canada, Alpha-Gal [sugar molecule found in mammals] allergies from tick bites may gain prevalence. These anaphylactic presentations often are associated with anaphylaxis that wakes a patient up at night, as they encounter a delayed anaphylactic reaction to red meat.

Patient Discharge and Follow-up

Our general threshold for prescribing an epinephrine autoinjector upon discharge should be very low. If you suspect anaphylaxis in any shape or form, it is always safer to simply Rx an autoinjector. Remember that idiopathic anaphylaxis [i.e. anaphylaxis without a clear trigger] is a medical entity, and therefore if you aren’t able to identify a trigger, but their symptoms were consistent with anaphylaxis, you SHOULD prescribe an autoinjector.

Apart from good discharge instructions on when to seek emergency medical attention, how to use their autoinjector safely, a good follow-up is needed for patients presenting with a first-time episode of anaphylaxis. Although human resource constraints for allergist are pronounced in some regions, a referral to a specialist is often beneficial in these individuals. Even if the “trigger” is clear, and the diagnosis of anaphylaxis is clear cut, these patients often have several lingering questions and a need for supports, as this dx will be a “lifelong” struggle. Our allergy specialists can help provide support and reassurance to individuals even if diagnostic clarification is not required.

 

Take-Home Points 

[TAKE HOME #1] There is ever growing evidence that observation times in the ED can be adjusted based on risk stratification. Although not quite ready for primetime, remember that those with high-risk features [listed below] should be observed for an extended period [i.e. >6hrs].

  • Cardiovascular disease
  • Lack of EMS services
  • Lack of access to epinephrine
  • Poor coping skills

[TAKE HOME #2] Even anaphylaxis has mimics. Consider alternative diagnoses including chronic urticaria and vocal cord dysfunction when epinephrine does not help.

[TAKE HOME #3] Every patient with suspected anaphylaxis should be discharged home with a Rx for an autoinjector, and counselled on it’s use/reasons to return to the ED.

[TAKE HOME #4] Referral to an allergist is not just for dx clarification. It provides an additional line of support for a patient who received an anaphylactic dx that will affect them the rest of their lives.

 

For more information make sure to check out the EMOttawaBlog post on ANAPHYLAXIS in the ED.

 

Episode 6: Tick Borne Illness Part 2 – Anaplasmosis

Episode 6: Tick Borne Illness Part 2 – Anaplasmosis

EMOttawa Podcast Episode 6
Tick Borne Illness Part 2 – Anaplasmosis

Click here for Part 1, focusing on Lyme disease.

In part 2 of our 2-part series on tick-borne diseases, Dr. Rajiv Thavanathan interviews Dr. Mikkey McGuinty, an infectious disease clinician-scientist on the topic of anaplasmosis. For a basic review of the disease and pathophysiology, we suggest our previous posts on lyme disease, vector borne illnesses part I and part II. 

Introduction

Anaplasmosis is the broad name for diseases cause by the Gram-negative bacterium Anaplasma phagocytophilumIt is a tick-borne illness, carried by the same Ixodes Scapularis tick that can cause Lyme disease. In humans, it’s called HumanGranulocytic Anaplasmosis (HGA). 

Why are we hearing about Anaplasmosis only recently?

Increased prevalence of ticks with climate change and the evolution of their habitat.

Up until 2020, many physicians had never seen HGA in Ottawa. There were 2 documented cases in Ontario over the last 5-years, both of which were in the Toronto region, which made sense given it’s proximity to the southernmost part of Ontario. Until recently clinicians were not routinely testing for it, and it’s likely that this represents an underestimation of the true prevalence. To date in 2021, there have been 5 documented hospital cases in the Ottawa region 

Epidemiology

  • In Ontario and most of Canada, the same as Lyme disease. That is, tick endemic regions.
    • Ticks in these regions are often found in areas with long grass and low brush. 
    • HGA is more common in Europe. It infects a different tick species (not Ixodes Scapularis), hence the difference in prevalence. 

Classic Presentation

  • Febrile, summer illness.
  • No erythema migrans.
  • Delayed presentation. On-average, illness occurs 1-2 weeks from exposure.
  • Symptoms are general and can include fever, fatigue, myalgias, headache, and less commonly, GI symptoms of nausea, vomiting or diarrhea.

Populations at Risk

  • Elderly (age >60), advanced HIV disease, or impaired T-cell immunity such as organ transplant recipients.
  • Unlike Lyme disease, most people will have a self-limited illness. It doesn’t have as delayed a presentation.
    • However, It can cause severe illness, including syndromes that look like septic shock because of cytokine response to the infection. You can have multi-organ system failure as a result, including brain disease, myocardial involvement, respiratory failure, severe hepatitis, renal failure.
  • 3-5% morbidity, with a case fatality rate of ~1%.

Diagnostic Clues

  • Cytopenia – particularly thrombocytopenia and leukopenia (less commonly anemia)
  • Mild biochemical hepatitis

 Advanced Testing

Bottom line: A challenging diagnosis to make in the ED. Needs to be a clinical diagnosis and confirmatory tests take a while to come back. 

  • Typically, morulae are found in the 1st 3-5 days of the infection, as opposed to later in the course.
  • Serology can be ordered but is only diagnostic when paired. You need an acute sample while sick, and a paired convalescent sample to determine the antigen titre delta.
  • PCR is the gold standard test, and the test of choice in regions with high prevalence.
    • In the ED, this could be helpful for high-suspicion presentations that will be treated empirically or referred to infectious disease.
      • A convincing clinical history, including tick exposure within the last 2-weeks now presenting with fever, myalgias and headache, with thrombocytopenia and biochemical hepatitis.

Prophylaxis & Treatment

  • Does doxycycline prophylaxis change the likelihood of developing HGA?
    • No, at least we don’t have data for it.
    • However, if they have risk factors (RF) for HGA, they have RF for Lyme disease, so if they meet tick criteria for doxycycline prophylaxis this should be given.
  • Treatment is Doxycycline 100mg PO BID x 10-14 days.
    • HGA is incredibly doxycycline sensitive, and the duration could be as short as 7-days, but we’re also concerned about treating Lyme disease.
  • The ID physician’s joke: No one should die without a trial of doxycycline.

Ottawa Specific Testing

At TOH

  • Epic doesn’t have HGA set up as a specific test for blood films
  • If you’re planning to order microscopy and asking to look for morulae, call the hematopathology team to inform them that HGA is on your differential.
    • Simply commenting on this in the EPIC comment section if often missed.

Take-Home Points

  • Anaplasmosis, also known as HGA, is a tick-borne illness carried by the same tick that can cause Lyme disease.
  • The classic presentation is a febrile summer illness, typically 7-days post tick exposure. Symptoms include fever, myalgias, headache, and less commonly, GI symptoms.
  • While typically self-limited, populations at risk of complications are the elderly (age >60), advanced HIV disease, or those with impaired T-cell immunity such as organ transplant recipients.
  • Suggestive lab abnormalities include thrombocytopenia, leukopenia, and mild biochemical hepatitis.
  • Testing in the ED can include ordering microscopy by hematopathology to look for morulae, which are intraneutrophilic bacterial bodies, with peak sensitivity on days 3-5.
  • PCR is the gold-standard test. For patients being treated empirically or referred to infectious disease, this can be considered.
  • Treatment: Doxycycline 100mg PO BID 10-14 days.
  • It’s never the wrong time to offer preventative care for tick-bites.

 

 

EMOttawa Podcast Episode 4: Reflections with Ian Stiell

EMOttawa Podcast Episode 4: Reflections with Ian Stiell

Podcast Episode #4 – Dr. Tiffany Lam & Dr. Ian Stiell

(Click here to access Podcast Main menu)

For our fourth episode of the Ottawa EM Podcast, Dr. Tiffany Lam makes her much anticipated Podcast debut! She sits down to talk to Dr. Ian Stiell, a world-renowned clinician and researcher best known for his development of the Ottawa EM decision rules.

How did you get involved in research?

It was ultimately unexpected, as I was not involved in research as a medical student or clinician. It began with leading journal club as a junior staff, learning how studies should be designed, and then going on to pursue a master’s in epidemiology.

Sometimes you need to go with your gut and follow any opportunities that arise, you can’t pre-ordain what’s going to happen.

Who were your mentors growing up?

My father was a forestry researcher, and although not a clinical researcher, I suppose this rubbed off. There was not a lot of emergency medicine research happening early-on in my career, so I relied on a multidisciplinary team of other clinicians early-on.

Advice for students or residents interested in emergency medicine research?

Reach out to known researchers as early as you can. If you’re a medical student, ask for opportunities in your 1st or 2ndyear volunteering or potentially working as a summer student. In Ottawa, there are multiple new EM projects happening each year, including opportunities to get involved helping with the resident research projects.

How does your clinical work influence your research?

After working in the ED for 40-years, it’s really a never-ending opportunity of ideas. Residents are always asking “why do you do it that way?” and you’re expected to know the answer. If you don’t, potentially there’s a new research idea. EM is unique in that we see the early stages of the undifferentiated patient. Whether in identification of disease, risk stratification or prognostication, there are always new opportunities for research in the ED.

What is the most meaningful change you’ve seen regarding the use of evidence in EM?

The shift away from eminence-based medicine, that is, away from old professors telling you what’s right just because it’s always been that way. Now we look at the studies first, and trainees are being taught earlier-on to critically appraise the literature.

How do you maintain a balanced schedule?

Part of it comes with learning how to be more efficient. Working hard, but also being proficient with your time. As an editor-and-chief for CJEM, this includes appraising articles quickly.

How does Ian Stiell prevent burnout?

Right now, it’s through having lots of hobbies outside of medicine and exercising. My hobbies have included skiing, mountain biking, playing golf, tennis and travelling when it’s not a global pandemic. Currently, I’ve been spending a lot of time with my family and grandchildren.

What are some of the greatest life lessons you’ve learned during your career?

You can’t totally preplan your life. In medical school I wanted to be a neurologist, then surgeon, then family doctor, and all of that seemingly went by the wayside as I grew up. You need to be open to new opportunities. Allow yourself to change course if you find something you like better. And don’t be afraid to admit you don’t like the path you’re on and change course.

What’s next for Dr. Ian Stiell?

I’m still actively involved in research, but part of my role has shifted more towards mentoring residents and new researchers. I’m also involved in working as the editor-and-chief of the Canadian Journal of Emergency Medicine (CJEM).

Any final parting words of advice?

While it depends on your personality, emergency medicine is an amazing career to pursue, particularly if you have a short-attention span. It’s exciting, fast paced, a team sport, and there are countless opportunities for clinical research—whether in quality improvement, simulation, or point-of-care ultrasound (POCUS) to name a few.